#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Inflammatory myofibroblastic tumour Oesophageal squamous cell carcinoma stage III Glomerulonephritis membranoproliferative Chronic myelomonocytic leukaemia Ventricular tachycardia Solitary fibrous tumour Ehlers-Danlos syndrome Leiomyosarcoma recurrent Deafness neurosensory Philadelphia positive acute lymphocytic leukaemia Palmar-plantar erythrodysaesthesia syndrome Dermatomyositis Neuroblastoma recurrent Malignant central nervous system neoplasm Piriformis syndrome More trials…

    Learn about Rare Diseases

    Synovial sarcoma – Diagnostics Retinitis pigmentosa – Trials in Disease Fragile X syndrome – Trials in Disease Hereditary angioedema – Treatment Carcinoid syndrome Haemophagocytic lymphohistiocytosis – Treatment Langerhans’ cell histiocytosis Breast angiosarcoma metastatic – Trials in Disease Myelodysplastic syndrome with excess blasts – Basic Information Soft tissue sarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    PALAZESTRANT Pamidronate Disodium Nadunolimab Amitriptyline OLVEREMBATINIB Quinine Dihydrochloride Telisotuzumab Vedotin Meloxicam Abt-494 Levothyroxine Sodium Tezacaftor Hmb-001 Tralokinumab Cladribine Omp64 Fidanacogene Elaparvovec Ep0042 Tovinontrine Magnesium Hydroxide Blu-222 More therapies…

    Learn about Your Condition

    Mantle cell lymphoma stage IV Glaucoma Prolymphocytic leukaemia Thrombotic microangiopathy Mucopolysaccharidosis I Abdominal pain Primary amyloidosis Psychotic disorder Immune-mediated enterocolitis Eosinophilic gastritis Mesothelioma Lung neoplasm malignant Ebola disease Behcet's syndrome Huntington's disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Lung adenocarcinoma

  • Durvalumab versus standard chemotherapy drug combination in elderly patients with advanced non‑small cell lung cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Lung adenocarcinoma
    Investigated Drugs:
    • Vinorelbine
    • Carboplatin
    • Cisplatin
    Italy

  • Study of bemarituzumab treatment for patients with solid tumors that have high levels of FGFR2b protein

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Lung adenocarcinoma
    • Cholangiocarcinoma
    • Breast cancer
    Investigated Drugs:
    • Bemarituzumab
    Austria Belgium Bulgaria Czechia Denmark Finland +9

  • Study on BI 907828 for Patients with Advanced Biliary Tract, Pancreatic, Lung, or Bladder Cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Biliary neoplasm
    • Lung adenocarcinoma
    • Pancreatic carcinoma
    Investigated Drugs:
    • (3S,3’S,3A’s,10A’s)-6-Chloro-3′-(3-Chloro-2-Fluorophenyl)-1′-(Cyclopropylmethyl)-6′-Methyl-2-Oxo-1,2,3′,3A’,10′,10A’-Hexahydro-1’H-Spiro[Indole-3,2′-Pyrrolo[2′,3′:4,5]Pyrrolo[1,2-B]Indazole]-7′-Carboxylic Acid
    Austria Belgium France Germany Spain

  • Study Comparing Atezolizumab and Drug Combination with Pembrolizumab and Drug Combination for Patients with Advanced Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Lung adenocarcinoma
    Investigated Drugs:
    • Atezolizumab
    • Carboplatin
    • Cisplatin
    Germany

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!